AXSM icon

Axsome Therapeutics
AXSM

Overview Fund Activity

290 hedge funds and large institutions have $3.15B invested in Axsome Therapeutics in 2024 Q4 according to their latest regulatory filings, with 62 funds opening new positions, 90 increasing their positions, 90 reducing their positions, and 39 closing their positions.

Holders
290
Holders Change
+15
Holders Change %
+5.45%
% of All Funds
3.86%
Holding in Top 10
11
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+37.5%
% of All Funds
0.15%
New
62
Increased
90
Reduced
90
Closed
39
Calls
$181M
Puts
$121M
Net Calls
+$59.4M
Net Calls Change
+$57.8M

Top Buyers

1
Lazard Asset Management
1
Lazard Asset Management
New York
$45.5M
2
BI
2
BVF Inc
California
$117M
3
Principal Financial Group
3
Principal Financial Group
Iowa
$17.5M
4
Citadel Advisors
4
Citadel Advisors
Florida
$41.9M
5
BNP Paribas Financial Markets
5
BNP Paribas Financial Markets
France
$15.7M

Top Sellers

1
DTC
1
Deep Track Capital
Connecticut
$0
2
FFM
2
Fairmount Funds Management
Pennsylvania
$124M
3
Bank of America
3
Bank of America
North Carolina
$17.3M
4
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$5.08M
5
Point72 Asset Management
5
Point72 Asset Management
Connecticut
$15.7M
Name Holding Trade Value Shares
Change 		Shares
Change %
CPA
326
Capital Performance Advisors
California
– -$899 -10 Closed
AWM
327
Avior Wealth Management
Nebraska
– -$898 -10 Closed
Allspring Global Investments
328
Allspring Global Investments
North Carolina
– -$808 -9 Closed
GM
329
GeoWealth Management
Illinois
– -$449 -5 Closed
10 11 12 13
14